Eptifibatide (Integrilin)

DRUG2 trials

Sponsors

Organon and Co, Xinqiao Hospital of Chongqing

Conditions

Acute Coronary SyndromeAcute Ischemic StrokeMyocardial Ischemia

Phase 3

EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)

CompletedNCT00089895

Organon and CoAcute Coronary Syndrome, Myocardial Ischemia

Start: 2004-11-01End: 2008-11-01Updated: 2024-05-17

Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis

Not yet recruitingNCT07347626

Xinqiao Hospital of ChongqingAcute Ischemic Stroke

Start: 2026-03-01End: 2029-12-31Target: 786Updated: 2026-01-16

Related Papers

Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography.

2020-01-0127 citations

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

2018-05-0121 citations

Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS.

2017-01-047 citations

Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials.

2016-03-0814 citations

Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.

2012-09-0110 citations

Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes.

2012-05-2956 citations

Early versus delayed, provisional eptifibatide in acute coronary syndromes.

2009-03-30300 citations